ロード中...
On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
Cancer is the second leading cause of death affecting nearly one in two people, and the appearance of new cases is projected to rise by >70% by 2030. To effectively combat the menace of cancer, a variety of strategies have been exploited. Among them, the development of peptide–drug conjugates (PD...
保存先:
| 出版年: | Beilstein J Org Chem |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Beilstein-Institut
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942387/ https://ncbi.nlm.nih.gov/pubmed/29765474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3762/bjoc.14.80 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|